Welcome to InCube Labs

InCube Labs, one of America’s most successful medical innovation centers, today announced it has broadened its focus to include pharmaceuticals and cell biology, and created an interdisciplinary team focused on tissue engineering and innovative drug delivery platforms. The company has added deep pharmaceutical expertise to support this aggressive research agenda, most notably with the addition of M. Hashim, R&D expert and former head of the Pharmacology Section at GlaxoSmithKline, North Carolina. Joining Hashim to drive InCube’s development of groundbreaking drug delivery methods is clinical development expert Sanjay Patel. The tissue engineering team welcomes Emily Arnsdorf (previously at Stanford University), biophysicist Lu Wang and micro-scale manufacturing design expert Paren Shah.

Medical device leaders from across the country, in both industry and academia, will converge at the University of Minnesota’s Eighth Annual Design of Medical Devices Conference (DMD) on Tuesday-Thursday April 14-16 at the Radisson University Hotel, 615 Washington Ave. S.E., Minneapolis. The conference will address major trends related to medical device design, policy, engineering, education and commercialization.

In a panel session on medical electronics Thursday morning (Jan. 8th) at the Consumer Electronics Show in Las Vegas, Howard Jay Chizek, a professor of electrical engineering at the University of Washington, posed—as one futuristic possibility in medicine—a scenario in which one doctor simultaneously directs robots doing several routine surgical procedures on different patients, without even washing his hands between operations.

These and other medical advances are within reach, according to the members of a panel called "Your Robot Will See You Now," except for one overshadowing issue: who pays and how.